Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort

Abstract

Consistent statistically significant reductions in pain scores at the aforesaid intervals compared to pretreatment means that there is a place for BTX in refractory TN.